Open Access
Subscription Access
Nursing Home Outreach Clinics show an improvement in patient safety and reduction in hospital admissions in residents with chronic conditions
Abstract
Background: In an environment of an ageing population, with patients exhibiting multiple co-morbidities and taking multiple drugs, as well as attending emergency departments with preventable admissions, the project team aimed to implement and evaluate nursing home outreach clinics.
Objectives: To demonstrate the benefit of holding consultant pharmacist-led medication review clinics in nursing homes; improve medication appropriateness and assess if a reduction in the number of hospital admissions was achievable.
Methods: Patients were reviewed in outreach clinics in the nursing homes. Data on patient age, number of drugs taken and clinical interventions made was collected for all patients seen. Monthly emergency department attendances were tracked and hospital admissions monitored. More detailed data was collected for 100 patients on type and significance of clinical interventions made, medication appropriateness, using the medication appropriateness index (MAI) and drug costs.
Results: Over a 12-month period, in 16 homes, 727 patients were reviewed and an average of 2.9 clinical interventions made per patient. Over the project duration, the average number of hospital admissions from these homes dropped from approximately 3.5 to 1.5 per month. Total estimated drug cost savings for the project over a 2-year time period were estimated at £213k. Individual and total MAI scores for 100 patients, evaluated in more detail, showed a highly significant improvement after clinic review (Wilcoxon Signed Rank test, p<0.001), indicative of more appropriate prescribing.
Discussion: Nursing home outreach clinics have resulted in cost-effective and safer patient care via significant clinical interventions and increased appropriateness of drugs prescribed for vulnerable older patients with complex needs.
Keywords
References
The Northern Ireland Statistics and Research Agency (NISRA). (2010). Single year population estimates of the number of persons aged 85 years and over in Northern Ireland. NISRA.
Montamat, S.C. & Cusack, B. (1992). Overcoming problems with polypharmacy and drug use in the elderly. Clinical Journal of Geriatric Medicine 24 (8) 143-158.
Barber, N, Alldred, D.P., Raynor, D.K., Dickenson, R., Garfield, S., Jesson, B., Lim, R., Savage, I., Standage, C., Buckle, P., Carpenter, J., Franklin, B., Woloshynowych, M. & Zermansky, A.G. (2009). Care homes use of medicines study: prevalence, causes and potential harm of medication errors in care homes for older people. Quality and Safety in Health Care 18 (5) 341-346.
Duerden, M., Avery, T. & Payne, R. (2013). Polypharmacy and medicine optimisation. London: Kings Fund.
Pulliam, C.C., Hanlon, J.T. & Moore, S.R. (1989). Contemporary issues in geriatric drug therapy. Journal of Geriatric Drug Therapy 4, 43-86.
Hanlon, J.T., Artx, M.B., Pieper, C.F., Lindblad, C.I., Sloane, R.J., Ruby, C.M. & Schmader, K.E. (2004). Inapproriate medication use among frail elderly inpatients. Annals of Pharmacotherapy 38 (1) 9-14.
Winterstein, A.G., Saver, B.C., Hepler, C.D. & Poole, C. (2002). Preventable drug related admissions. Annals of Pharmacotherapy 36,1238-1248.
CHUMS. (2015). http://www.birmingham.ac.uk/Documents/college-mds/haps/projects/cfhep/prsp/finalreports/PS025CHUMS-FinalReport with appendices.pdf (Accessed 12 Nov 2015).
Royal Pharmaceutical Society. (2014). Pharmacists improving care in care homes. September 14.
Northumbria Healthcare Trust. (2012).http://www.health.org.uk/areas-of-work/programmes/shine-twelve/related-projects/northumbria-healthcare-nhs-foundation-trust/learning/ (Accessed 12 November 2015).
Crotty, M., Halbert, J., Rowett, D., Giles, L., Birks, R., Williams, H. & Whitehead, C. (2004). An outreach geriatric medication advisory service in residential aged care: a randomised controlled of case conferencing. Age and Ageing 33 (6) 612-617.
Hanlon, J.T., Schmader, K.E., Samsa, K.E., Weinberger, M., Uttech, K.M., Lewis, I.K., Cohen, H.J. & Feussner, J.R. (1992). A method for determining drug therapy appropriateness. Journal of Clinical Epidemiology 45 (10) 1045-1051.
Eadon, H. (1992). Assessing the quality of ward pharmacists’ interventions. International Journal of Pharmacy Practice 1, 145-147.
NHS Directory of Medicines and Devices. http://www.dmd.nhs.uk/ (last accessed October 14th 2014).
DHSSPSNI. Northern Ireland Schedule Reference Costs, 2010-11.
Burnett, K.M., Scott, M.G., Fleming, G.F., Clark, C.M. & McElnay, J.C. (2009). Effects of an integrated medicines management program on medication appropriateness in hospitalized patients. American Journal of Health-System Pharmacy 66, 854-858.
East and South East England Specialist Pharmacy Service. (2015). Seven steps to managing polypharmacy. London.
All Wales Strategy Group. (2014). Polypharmacy. Guidance for Prescribing in Frail Adults.
Barnett, N. (2012). PREVENT tool. High risk patient referral tool. http://www.pharmaceutical-journal.com/files/rps-pjonline/Simple%20Tools.pdf (Accessed 12 Nov 2015).
O’Mahony, D., O’Sullivan, D., Byrne, S., O’Connor, M.N., Ryan, C. & Gallagher, P. (2014). STOPP/START criteria for potentially inappropriate prescribing in older people version 2. Age and Ageing 44 (2) 213-218.
Holland, R., Desborough, J., Goodyer, L., Hall, S., Wright, D. & Loke, Y.K. (2008). Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. British Journal of Clinical Pharmacology 65 (3) 303-316.
Royal, S., Smeaton, L., Avery, A.J., Hurwitz, B. & Sheikh, A. (2006). Interventions in primary care to reduce medication related adverse effects and hospital admissions: systematic review and meta-analysis. Quality and Safety in Health Care 15, 23-31.
DOI: http://dx.doi.org/10.5750/ejpch.v4i4.1178
Refbacks
- There are currently no refbacks.